|Systematic (IUPAC) name|
|Mol. mass||219.32264 g/mol|
| (what is this?)
Zylofuramine is a stimulant drug. It was developed in 1961, and was intended for use as an appetite suppressant and for the treatment of senile dementia in the elderly, but there is little information about it and it does not appear to have ever been marketed.
Zylofuramine is legal throughout the world. Its chemical structure has a vague similarity to other N-ethyl substituted stimulant drugs such as ethylamphetamine, but its structure would probably not be close enough for it to be considered a controlled substance analogue.
- US patent 3091621, Clarke, R. L., "Alpha-Aryl or Aralkyl Tetrahydrofurfurylamines", issued 1963-05-28, assigned to Sterling Drugs
- Clarke, R. L.; Harris, L. S. (1962). "α-Benzyltetrahydrofurfurylamines -- A New Series of Psychomotor Stimulants. I". Journal of Medicinal Chemistry 5 (1): 77–95. doi:10.1021/jm01236a010. PMID 14046619.
- Clarke, R. L.; Tullar, B. F.; Harris, L. S. (1962). "α-Benzyltetrahydrofurfurylamines -- A New Series of Psychomotor Stimulants. II. Resolution of Isomers". Journal of Medicinal Chemistry 5 (2): 362–372. doi:10.1021/jm01237a014. PMID 14051912.
- Harris, L. S.; Clarke, R. L.; Dembinski, J. R. (1963). "α-Benzyltetrahydrofurfurylamines -- A New Series of Psychomotor Stimulants. III. The Pharmacology of D-Threo α-Benzyl-N-Ethyltetrahydrofurfurylamine (Zylofuramine)". Archives Internationales de Pharmacodynamie et de Thérapie 146: 392–405. PMID 14099588.
|This drug article relating to the gastrointestinal system is a stub. You can help Wikipedia by expanding it.|